Transmission of hepatitis B virus from hepatitis B core antibody- positive donors in living related liver transplants

Transplantation

Volumn 65, Issue 4, 1998, Pages 494-499

  Uemoto, Shinji ^a   Sugiyama, Kohachiro ^b   Marusawa, Hiroyuki ^a   Inomata, Yukihiro ^a   Asonuma, Katsuhiro ^a   Egawa, Hiroto ^a   Kiuchi, Tetsuya ^a   Miyake, Yoshishige ^b   Tanaka, Koichi ^a   Chiba, Tsutomu ^a  

^a KYOTO UNIVERSITY   (Japan)

^b NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; INFECTION RISK; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; ORGAN DONOR; PRIORITY JOURNAL; VIRUS TRANSMISSION;

DNA, VIRAL; FAMILY; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B ANTIGENS; HEPATITIS B CORE ANTIGENS; HEPATITIS B VIRUS; HUMANS; LIVER TRANSPLANTATION; LIVING DONORS; POLYMERASE CHAIN REACTION;

EID: 0032570862     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199802270-00007     Document Type: Article

References (28)

1. Wolf JL, Perkins HA, Schreeder MT, Vincenti F. The transplanted kidneys as a source of hepatitis B infection. Ann Intern Med 1979; 91: 412.
2. Chan MK, Chang WK Renal transplantation from HBsAg positive donors to HBsAg negative recipients. Br Med J 1988; 297: 522.
3. Lutwick LI, Sywassink JM, Corry RJ, Shorey JW. The transmission of hepatitis B by renal transplantation. Clin Nephrol 1983; 19: 317.
4. Wachs ME, Amend WJ, Ascher NL, et al. The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors. Transplantation 1995; 59: 230.
5. Inomata Y, Tanaka K, Egawa H, et al. The evolution of immunosuppression with FK506 in pediatric living-related liver transplantation. Transplantation 1996; 61: 247.
6. Oda T, Sugiyama K. Hepatitis B virus S genome analysis of babies born to hepatitis B e antigen positive carrier mothers. Nagoya Med J 1994; 39: 47.
7. Ono Y, Onda H, Sasada R, Igarashi K, Sugino Y, Nishioka K. The complete nucleotic sequences of the cloned hepatitis B virus DNA: subtype adr and adw. Nucleic Acids Res 1983; 11: 1747.
8. Okamoto H, Tsuda F, Sakugawa H, et al. Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes. J Gen Virol 1988; 69: 2575.
9. Krugman S, Overby LR, Mushahwar LK, Ling C, Frosner GG, Deinhardt F. Viral hepatitis B: studies on natural history and prevention re-examined. N Engl J Med 1979; 300: 101.
10. Blum HE, Offensperger WB, Walter F, Offensperger S, Gerok W. Latent hepatitis B virus infection with full-length viral genome in a patient serologically immune to hepatitis B virus infection. Liver 1988; 8: 307.
11. Blum HE, Linag TJ, Galin E, Wands JR. Persistence of hepatitis B viral DNA after serological recovery from hepatitis B virus infection. Hepatology 1991; 14: 56.
12. Adachi H, Kaneko S, Matsushita E, Inagaki Y, Unoura M, Kobayashi K. Clearance of HBsAg in seven patients with chronic hepatitis B. Hepatology 1992; 16: 1334.
13. Kuhns M, McNamara A, Mason A, Campbell C, Perrillo R. Serum and liver hepatitis B virus DNA in chronic hepatitis B after sustained loss of surface antigen. Gastroenterology 1992; 102: 1649.
14. Michalak TI, Pasquinelli C, Guilhot S, Chisari FV. Hepatitis B virus persistence after recovery from acute viral hepatitis. J Clin Invest 1994; 93: 230.
15. Hoofnagle JH, Seeff LB, Bales ZB, et al. Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen. N Engl J Med 1978; 298: 1379.
16. Iizuka H, Ohmura K, Ishijima A, et al. Correlation between anti-HBc titers and HBV DNA in blood units without detectable HBsAg. Vox Sang 1992; 63: 107.
17. Japanese Red Cross Non-A, Non-B Hepatitis Research Group. Effect of screening for hepatitis C virus antibody and hepatitis B virus core antibody on incidence of posttransfusion hepatitis. Lancet 1991; 338: 1040.
18. Chazouilleres O, Mamish D, Kim M, et al. "Occult" hepatitis B virus as source of infection in liver transplant recipients. Lancet 1994; 343: 142.
19. European FK506 Multicentre Liver Study Group. Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. Lancet 1994; 344: 423.
20. McDiarmid SV, Busuttil RW, Ascher NL, et al. FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Transplantation 1995; 59: 530.
21. Neuhaus P, Blumhardt G, Bechstein WO, et al. Comparison of FK506- and cyclosporine-based immunosuppression in primary orthotopic liver transplantation. Transplantation 1995; 59: 31.
22. Hepatitis and hepatocellular carcinoma in South Asia. WHO Assignment Report ICO RPD002SEA 1982.
23. Ihara H, Kato T, Ikeda H, Sekiguchi S. Evaluation of HI method as an anti-HBc screening test. Jpn J Transfusion Med 1990; 36: 56.
24. Samuel D, Rainer M, Graeme A, et al. Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med 1993; 329: 1842.
25. McGory RW, Ishitani MB, Oliveira WM, et al. Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization. Transplantation 1996; 61: 1358.
26. Terrault NA, Zhou S, Combs C, et al. Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin. Hepatology 1996; 24: 1327.
27. Carman WF, Zanetti AR, Karayiannis P, et al. Vaccine-induced escape mutant of hepatitis B virus. Lancet 1990; 336: 325.
28. Hino K, Okuda M, Hashimoto O, et al. Glycine-to arginine substitution at codon 145 of HBsAg in two infants born to hepatitis B e antigen-positive carrier. Dig Dis Sci 1995; 40: 566.